Pricing of oral generic cancer medicines in 25 European countries; findings and implications

Brian Godman, Andrew Hill, Steven Simoens, Amanj Kurdi, Jolanta Gulbinovič , Antony Martin, Angela Timoney, Dzintars Gotham, Janet Wale, Tomasz Bochenek , Celia Rothe, Iris Hoxha, Admir Malaj, Christian Hierländer, Robert Sauermann, Wouter Hamelinck, Zornitza Mitkova, Guenka Petrova, Ott Laius, Catherine SermetIrene Langer, Gisbert Selke, John Yfantopoulos, Roberta Joppi, Arianit Jakupi, Elita Poplavska, Ieva Greiciute-Kuprijanov, Patricia Vella Bonanno, JF Piepenbrink, Vincent de Valk, Carolin Hagen, Anne Marthe Ringerud, Robert Plisko, Magdalene Wladysiuk, Vanda Marković-Peković, Nataša Grubiša, Ileana Mardare, Tanja Novakovic, Tatjana Ponorac, Mark Parker, Jurij Fürst, Dominic Tomek, Mercè Obach Cortadellas, Corrine Zara, Maria Juhasz-Haverinen, Peter Skiold, Stuart McTaggart, Alan Haycox

Research output: Contribution to journalArticlepeer-review

62 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Pricing of oral generic cancer medicines in 25 European countries; findings and implications'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds